Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

EXPLAINED: Sturgis - The Real Truth

Watch Harley-Davidson Demolish a World-Record Jump at Sturgis Rally

Colby Raha set out to break the world record for the longest distance jumped on a Harley-Davidson at the Sturgis Motorcycle Rally.

RideApart

‘We could just have a blast’: Trump invited to attend Sturgis motorcycle rally

Sen. Rounds invited Trump to attend the annual Sturgis Motorcycle Rally, saying he would “be impressed with the reception.”

The Independent UK

A Couple Maniacs Swapped a Go-Kart Engine Into a Mobility Scooter

There's no shortage of insanity-induced projects on the web. From twin Hayabusa-engined crosskarts, Zero-powered trikes, ATV robot dogs, and Harley snowbikes, the denizens of the internet are nothing if not resourceful with the leftover parts that they have in their garages, as well as psychotic. And that's why we love…

RideApart

From analysis to the latest developments in health,
read the most diverse news in one place.

Taking a Monster Chopper to Sturgis? Sure, Why Not

Grind Hard Plumbing Co's monster chopper KTM is alive and well. It's also street-legal. So what do you do to christen it? Ride it to Sturgis, duh.

RideApart

Roland Sands And Royal Enfield Reveal Custom Super Meteor 650 At Sturgis

Roland Sands Design and Royal Enfield collaborated on a one-of-a-kind custom Super Meteor 650 build for the annual Motorcycles as Art show at Sturgis 2023.

RideApart

Is Abbott Stock a Buy at $105 as Production in Troubled Plant Resumes?

Leading healthcare company Abbott Laboratories (ABT) reported robust first-quarter results. And the company is well-positioned to benefit from its diversified business. Moreover, as ABT is resuming infant formula production at its Michigan facility, is the stock a good buy at the current price level? Read more to find out….

StockNews.com

Abbott reopens Michigan baby formula plant after flooding

Abbott's facility has now closed and reopened twice this year. The baby formula plant had previously closed in February because of bacterial contamination.

WEKU

Read news from The Economist, FT, and more,
with one subscription

Hopes US baby formula shortage could ease as key Abbott plant restarts

Factory in Sturgis, Michigan shut down in May after storms that produced torrential flooding

The Guardian - US

Abbott again halting baby formula production at its Michigan facility after flooding

Less than two weeks after restarting formula production at its Michigan facility, Abbott has again had to halt manufacturing there amid flooding.

Chicago Tribune

Abbott's baby formula plant closes again after severe storms and flooding

Abbott's Sturgis, Mich., plant was open for less than two weeks before it had to close again after flooding from severe weather. The company said it hopes to resume production in a few weeks.

WEKU

More Trouble For Baby Formula Production As Thunderstorms, Flood, Hit Abbott's Troubled Michigan Plant

Just a few weeks after reopening its baby formula Sturgis, Michigan plant, Abbott Laboratories (NYSE:ABT) said it paused EleCare specialty baby formula production after recent thunderstorms flooded part of the facility. The company has informed the FDA and will conduct comprehensive testing with an independent third party to ensure the plant is safe to…

Benzinga

Abbott halts production at Michigan baby formula plant after storm causes flooding

The beleagured Sturgis plant only resumed production less than 2 weeks ago.

Axios

Michigan baby formula maker resumes production after safety shutdown

The Abbott facility was closed in February after a recall involving bacterial infections in infants which led to a nationwide shortage

The Guardian - US

Abbott reopens baby formula plant in Michigan

Abbott Laboratories said on Saturday that it has reopened its baby formula production plant in Sturgis, Michigan, taking a step toward alleviating an acute nationwide shortage that has sent parents scrambling for supplies.

Reuters

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Lawmakers Seek Answers From FDA, Abbott On Nationwide Baby Formula Shortage

FDA officials appeared before a congressional panel to answer questions about the crisis after Abbott Laboratories (NYSE: ABT) recalled some baby formula products and closed its manufacturing plant in Sturgis, Michigan.

Salon

Abbott enriched investors amid outbreak

Documents show the baby formula maker increased payouts to investors as tainted formula allegedly sickened babies

The Guardian - US

Baby formula crisis: Abbott enriched shareholders as factory needed repairs, records show

Economists condemn ‘rot’ in system after manufacturer issued billions in stock buybacks despite problems at Michigan factory

Benzinga

Abbott's Troubled Baby Formula Michigan Plant To Reopen In 1-2 Weeks: Reuters

Abbott Laboratories (NYSE:ABT) and the FDA are reportedly on track to reopen the company's Sturgis, Michigan, baby formula manufacturing plant within one or two weeks, FDA Commissioner Robert Califf said. Abbott, the biggest U.S. supplier of powder infant formula, including Similac, agreed with the FDA on the steps needed to resume production at…

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation

Baby formula industry was primed for disaster long before key factory closed down

The conditions that led to a shortage of baby formula were set in motion long before the February 2022 closure of the Similac factory tipped the U.S. into a crisis.

Tribune News Service

Viewpoint 3: To avoid the next infant formula crisis, make food safety a priority

The Food and Drug Administration has reached an agreement with Abbott Laboratories to resume production at the company’s Sturgis, Michigan, facility. The announcement gives hope of relief for the three-fourths of American parents who rely on infant formula, and have struggled to find the product in recent weeks.

Chicago Sun-Times

Deal reached to reopen baby formula plant, Abbott says

The company, headquartered in Chicago, did not immediately detail terms of the agreement with the Food and Drug Administration, which has been investigating safety concerns at the firm’s Sturgis, Michigan, plant.

The Independent UK

House Oversight Committee launches probe into baby formula manufacturers amid nationwide shortage

‘The national formula shortage poses a threat to the health and economic security of infants and families in communities across the country,’ lawmakers write

Benzinga

Amid Baby Formula Shortage, Retailers Put Cap On Purchases: Report

The U.S. faced a nationwide shortage of the most popular baby formula brands in the week starting April 24, according to the latest figures from Datasembly, which tracks out-of-stock messages on retailers' websites and apps. An average rate is less than 10%. Reasons For The Shortage: Supply chain issues caused by the COVID-19…

Chicago Sun-Times

Baby formula shortage continues after Abbott Nutrition recall: Nearly 30% of popular brands sold out

It’s been harder to find since Abbott Nutrtion issued a recall in February for select lots of Similac, Alimentum and EleCare formulas made at a plant in Sturgis Michigan.

Benzinga

FDA Inspection Flags Quality Control Issues At Abbott's Michigan Facility

An inspection at the Abbott Laboratories (NYSE: ABT) facility in Sturgis, Michigan,

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.